4 completed, 1 withdrawn. 2 Not applicable, 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Dermatitis, Perioral: new trials by email Literature Review of Dermatitis, Perioral trials Research Report on Dermatitis, Perioral
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Cream Paste Containg Pleuran on Selected Skin Dermatoses (Neonatal Pustulosis, Diaper Dermatitis, Perioral Dermatitis). Cosmetic product: Imunoglukan P4H® ACUTE! cream-paste - Diaper Dermatitis, Perioral Dermatitis | Not applicable | Completed | Pleuran, s.r.o. | 110 | 2024-05-01 | 2026-03-23 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Sarecycline for Treating Periorificial Dermatitis Seysara Oral Product - Perioral Dermatitis | Phase 4 | Completed | The Dermatology Institute of Boston | 9 | 2023-07-17 | 2024-06-21 |
| Laser Therapy for Perioral Dermatitis Pulse laser dye therapy (Device name: Candela Family of Pulsed Dye Laser Systems. 501k Number: K050673.), Clindamycin - Perioral Dermatitis | Not applicable | Withdrawn | West Virginia University | 2018-11-01 | 2022-03-03 | |
| A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis Azelaic acid 15% gel, Non-active base from azelaic acid 15% gel - Perioral Dermatitis | Phase 2 | Completed | LEO Pharma | 48 | 2006-11-01 | 2023-06-09 |
| Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis Pimecrolimus, Placebo - Perioral Dermatitis | Phase 3 | Completed | Novartis | 124 | 2005-09-01 | 2008-01-17 |
Diaper Rash (1) · Erythema (1)
Dermatitis (5) · Facial Dermatoses (5) · Skin Diseases (5) · Skin and Connective Tissue Diseases (5) · Dermatitis, Contact (1) · Dermatitis, Irritant (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1) · Skin Diseases, Eczematous (1) · Skin Manifestations (1)
Clindamycin (1) · Gels (1) · azelaic acid (1) · pimecrolimus (1)
LEO Pharma (1) · Novartis (1) · Pleuran, s.r.o. (1) · The Dermatology Institute of Boston (1) · West Virginia University (1)
Germany (2) · United States (2) · Slovakia (1)
Karolina Vorcakova, MD., PhD. (1)